Pedi Dose Plus

60
Pedi Dose Plus
Pedi Dose Plus is an Android app from Dr Mostafa Mahmoud in the Medical category, currently rated 4.6★ across 607 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 60: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 💎 In-app purchase plumbing | +$9K |
| ⚙ Medical complexity ×1.55 | +$32K |
| 🌐 Cross-platform reach (iOS + Android) | +$50K |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Insufficient data · 34/100MICRO TIERtoo early to score- 💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
- ⭐ Quality: 4.8★ across 81 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Excellent rating (4.6★)METRIC | +$2,200 | |
| Established app (5y old)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Early-stage install base (607 ratings)METRIC | +$400 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Pedi Dose Plus
- Developer
- Dr Mostafa Mahmoud
- Bundle ID
- com.companyname.pedi_dose_app
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- dr-mostafa-mahmoud-ali.blogspot.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $247/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $2.49 - $99.99 per item
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth607 ratings+104% lifetimeShow 3-year history estimate ▾
📝 About this app
The Pedi Dose program calculates the dosages of all children's medications (Egyptian medications) based on the active ingredient or brand name, age, and weight.
Pedi Dose Plus includes alternatives (similars) of the active ingredient available in Egypt.
Pedi Dose Plus includes warnings and precautions.
Pedi Dose Plus includes contraindications.
Pedi Dose Plus includes information on medications used in patients with G6PD deficiency.
Pedi Dose Plus includes daily topics.… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
Why medium confidence: 607 ratings · no founder-verified revenue (model estimate only).




